Philippines - English - FDA (Food And Drug Administration)

elanco philippines, inc. - inactivated rabies virus vaccine (vet.) - suspension for injection (im/sc) - each ml contains: rabies virus (sad vnukovo-32 strain).. iu - intemational unit >2 iu

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - inactivated rabies virus, strain vnukovo-32 - suspension for injection - unknown - rabies virus vaccine - bovine, canine, caprine, equine - food, feline, ferret, ovine, porcine - immunological - inactivated vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - inactivated rabies virus, strain vnukovo-32 - suspension for injection - minimum 2.0 international unit(s) - rabies virus - cats, cattle, dogs, ferrets, goats, horses, pigs, sheep - immunological - inactivated vaccine

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

European Union - English - EMA (European Medicines Agency)

zoetis belgium s.a. - canine parainfluenza virus, leptospira and rabies virus. - immunologicals for canidae, live and inactivated viral and bacterial vaccines - dogs - active immunization of dogs from six weeks of age to prevent clinical signs and reduce viral excretion cause by canine parainfluenza virus, to prevent clinical signs, infection and urinary excretion cause by leptospira serovars bratislava, canicola, grippotyphosa and icterohaemorrhagiae and to prevent mortality, clinical signs and infection cause by rabies virus.

Philippines - English - FDA (Food And Drug Administration)

broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine parainfluenza virus , canine adenovirus (cav) , canine parvovirus , inactivated leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola , l. kirschneri ser. grippotyphosa , l. interrogans ser. bratislava , rabies virus vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each dose (1 ml) contains: canine distemper virus (cdv bio 11/a strain)- 10^3.1 to 10^5.1 tcid50 canine parainfluenza type 2 virus (cpiv-2-bio 15 strain)-- 10^3.1 to 10^5.1 tcid50 canine adenovirus type 2 (cav-2-bio 13 strain)-10^3.6 to 10^5.3 tcid50 canine parvovirus type 2b (cpv-2b bio 12/b strain)-10^4.3 to 10^6.6 tcid50 leptospira interrogans ser. icterohaemorrhagiae (mslb 1089 strain)- >1:51 alr (gmt) ser. canicola (mslb 1090 strain)-- >1:51 alr (gmt) ser. bratislava (mslb 1088 strain)- >1:51 alr (gmt) leptospira kirschneri ser. grippotyphosa (mslb 1091 strain)- >1:40 alr (gmt) rabies virus (sad vnukovo-32 bio 16 strain)-> 2.0 iu tcid-tissue culture infect dose 50% gmt-geometric moon titre alr-agglutination lyuis reacties

Ireland - English - HPRA (Health Products Regulatory Authority)

gsk vaccines gmbh - rabies virus (flury lep) inactivated - infus/pdr/oral soln - >= 2.5 international unit(s)/millilitre - rabies vaccines; rabies, inactivated, whole virus

United States - English - NLM (National Library of Medicine)

gsk vaccines gmbh - rabies virus strain flury lep antigen (propiolactone inactivated) (unii: fk894q51ye) (rabies virus strain flury lep antigen (propiolactone inactivated) - unii:fk894q51ye) - rabies virus strain flury lep antigen (propiolactone inactivated) 2.5 [iu] in 1 ml - rabavert is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups. usually, an immunization series is initiated and completed with one vaccine product. no clinical studies have been conducted that document a change in efficacy or the frequency of adverse reactions when the series is completed with a second vaccine product. however, for booster immunization, rabavert was shown to elicit protective antibody level responses in persons tested who received a primary series with hdcv (4,11). (see also dosage and administration section below) preexposure vaccination consists of three doses of rabavert 1.0 ml, intramuscularly (deltoid region), one each on days 0, 7, and 21 or 28 (1) (see also table 1 for criteria for preexposure vaccination). preexposure vaccination does not eliminate the need for additional therapy after a known rabies exposure (see also dosage and administration section, subsection c). preexposure vaccina

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - rabies virus - suspension for injection - inactivated viral vaccine - cats, cattle, dogs, ferrets, goats, horses, pigs, sheep

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - rabies virus - suspension for injection - inactivated viral vaccine - cats, cattle, dogs, ferrets, goats, horses, pigs, sheep